Epigenetics for the pediatric cardiologist. Congenit Heart Dis 2017 Dec;12(6):828-833
Date
10/07/2017Pubmed ID
28984030DOI
10.1111/chd.12543Scopus ID
2-s2.0-85035746507 (requires institutional sign-in at Scopus site) 7 CitationsAbstract
A genetic basis of congenital heart disease (CHD) has been known for decades. In addition to the sequence of the genome, the contribution of epigenetics to pediatric cardiology is increasingly recognized. Multiple epigenetic mechanisms, including DNA methylation, histone modification, and RNA-based regulation, are known mediators of cardiovascular disease, including both development and progression of CHD and its sequelae. Basic understanding of the concepts of epigenetics will be essential to all pediatric cardiologists in order to understand mechanisms of pathophysiology, pharmacotherapeutic concepts, and to understand the role of epigenetics in precision medicine.
Author List
Spearman ADAuthor
Andrew Spearman MD Associate Professor in the Pediatrics department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
CardiologistsCardiovascular Diseases
Child
Clinical Competence
Epigenesis, Genetic
Humans









